Claim(permalink)
On April 18, 2023, the U.S. Federal Drug Administration updated existing guidelines to no longer authorize the use of monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines.
Factors
veracity
Political Leaning
Sentiment
Date published
2023-04-19

